Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Debt Ratio (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Debt Ratio for 16 consecutive years, with 0.09 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt Ratio fell 51.23% year-over-year to 0.09, compared with a TTM value of 0.09 through Sep 2025, down 51.23%, and an annual FY2024 reading of 0.17, up 10.21% over the prior year.
  • Debt Ratio was 0.09 for Q3 2025 at China Pharma Holdings, down from 0.2 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.28 in Q3 2022 and bottomed at 0.09 in Q3 2025.
  • Average Debt Ratio over 5 years is 0.18, with a median of 0.17 recorded in 2023.
  • The sharpest move saw Debt Ratio skyrocketed 116.3% in 2021, then plummeted 51.23% in 2025.
  • Year by year, Debt Ratio stood at 0.19 in 2021, then dropped by 28.19% to 0.14 in 2022, then grew by 12.62% to 0.15 in 2023, then increased by 10.21% to 0.17 in 2024, then plummeted by 47.51% to 0.09 in 2025.
  • Business Quant data shows Debt Ratio for CPHI at 0.09 in Q3 2025, 0.2 in Q2 2025, and 0.18 in Q1 2025.